Fujifilm Diosynth Biotechnologies, a leading CDMO in the field of biologics, vaccines, advanced therapies, and oncolytic viruses, has embarked on the initial phase of a massive expansion project at their facility in Hillerød, Denmark. By adding six mammalian cell bioreactors to the existing
The biopharma industry in the United States continues to thrive, driven by innovation, substantial funding, and strategic collaborations. As we look ahead to 2024, certain regions stand out as leading hubs for biopharma activity. The evolution of these hubs is fueled by various factors, including
The establishment of the BioHub Maryland Training and Education Center in Montgomery County marks a pivotal moment for the biopharma industry, both locally and nationally. With a $3 million investment from Montgomery County coupled with an additional $1.25 million from the Moore-Miller
Abzena, a contract development and manufacturing organization (CDMO) specializing in complex biologics and bioconjugates, has announced an expansion of its quality control (QC) testing capabilities with a new microbiology lab in San Diego. The new facility is dedicated to enhancing analytical
In a significant advancement for International Process Plants (IPP), the Universal Glasteel Equipment (UGE) subsidiary has attained the American Society of Mechanical Engineers (ASME) 'R' Certificate for its facility in Eastover, South Carolina. This recent recognition permits IPP to carry out
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals and advanced therapy medicinal products (ATMPs), has taken a monumental step towards bolstering its operational capabilities. The German-based company has announced its
